2 results
Approved WMOCompleted
Time to recurrence of sustained VT and/or appropriate ICD therapy; ATP or shock
Approved WMOPending
This study is evaluating the preliminary efficacy of UV1-olaparib-durvalumab combination against both olaparib as monotherapy and olaparib-durvalumab combination in maintenance after platinum combination therapy for BRCAwt patients with relapsed…